Earnings call transcript: Kyndryl Holdings misses Q4 2026 earnings expectations By Investing.com

Kyndryl missed Q4 FY2026 expectations with EPS of $0.18 versus $0.49 consensus and revenue of $3.77B versus $3.98B expected, sending the stock down 13.64% in pre-market trading. FY2026 revenue was flat at $15.1B, though adjusted EBITDA rose to $2.7B with 100bps margin expansion and free cash flow totaled $406M. Management guided FY2027 revenue to flat-to-down 2% in constant currency and warned that IBM-related headwinds and elongated sales cycles will continue, even as hyperscaler revenue grew 59% YoY.

Analysis

KD is a classic “good business, bad tape” setup: the market is punishing the revenue guide, but the real signal is that the mix is migrating toward higher-quality, higher-margin work faster than headline growth can show it. That makes the earnings miss more about timing and customer decision latency than about demand destruction, which is why the downside could stabilize once investors model the 2H ramp and the incremental margin from workforce actions. The bigger issue is not the quarter, but the credibility gap between management’s confidence and the market’s willingness to underwrite another year of subscale top-line progress.

Second-order, the IBM dynamic matters more for IBM than for KD. If customers are choosing to bypass the integrator and buy more directly, that compresses IBM’s addressable services adjacency and weakens the “platform plus services” monetization flywheel, while also pressuring IBM partners that depend on attached content. Conversely, hyperscaler and infrastructure-modernization spend looks resilient, which is structurally supportive for AMD/AVGO/DELL only to the extent that AI and cloud capex keeps displacing legacy spend; this is not a broad IT-spend reacceleration, it is a mix shift.

The contrarian read is that KD may be closer to trough optics than the chart suggests. If the company executes the planned cost reset, the P&L can re-rate even with flat-to-down revenue because the market is currently discounting operating slippage, not just growth scarcity. The risk is a multi-quarter holding pattern: if signings convert slower than expected, the stock can keep de-rating despite apparent undervaluation, since the market will not pay for backlog quality it cannot see in reported revenue.

For IBM, the reaction is negative in second order: not because KD is economically important, but because it highlights that IBM-related content can be monetized outside the direct customer relationship. That is a subtle but real margin-risk narrative for IBM over the next 2-4 quarters if more clients prioritize control, sovereignty, and direct procurement over bundled delivery.

Key Decisions for Investors

• Short KD into any post-earnings relief rally over the next 1-3 weeks; thesis is that guidance still implies no near-term revenue inflection, while margin actions are already partially reflected. Use a tight stop above the pre-miss gap fill and target a 10-15% retracement if the market stays focused on growth.
• Pair trade: long IBM put spread / short KD common for 2-4 months. KD is absorbing the immediate revenue damage, but IBM faces the slower-burn risk that customers increasingly unbundle content and buy direct. Risk/reward favors a relative-value stance because KD’s multiple already reflects distress while IBM still carries higher expectations.
• Buy AMD on weakness, but only as a tactical beneficiary of AI infrastructure spend over 1-3 months. KD’s commentary reinforces that modernization budgets are being reallocated toward AI, sovereign cloud, and high-value compute rather than broad services, which should keep AMD’s narrative supported; stop if enterprise capex commentary rolls over.
• Avoid chasing DELL as a proxy for the article’s AI theme; the signal here is services mix-shift, not general hardware demand. If anything, use rallies to trim hardware exposure unless checks confirm a fresh capex cycle.
• If you want a contrarian long, express it through KD call spreads 3-6 months out only after the market digests the guide cut. The setup is attractive only if execution on workforce savings and signings conversion becomes visible; otherwise theta bleed will dominate.